MYNZ logo

Mainz Biomed BV (MYNZ) Company Overview

Profile

Full Name:

Mainz Biomed N.V.

Sector:

Healthcare

Country:

Germany

IPO:

November 5, 2021

Indexes:

Not included

Description:

MYNZ (Mainz Biomed BV) is a biotechnology company focused on developing innovative diagnostic solutions for early disease detection. They specialize in molecular tests, particularly for gastrointestinal diseases, aiming to improve patient outcomes through advanced technology and personalized healthcare solutions.

Key Details

Price

$5.80

Annual Revenue

$895.50 K(+68.99% YoY)

Annual EPS

-$64.80(+12.90% YoY)

Annual ROE

-303.20%

Beta

0.18

Events Calendar

Earnings

Next earnings date:

Feb 25, 2025

Recent quarterly earnings:

Oct 21, 2024

Recent annual earnings:

Apr 10, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 3, 2024

Analyst ratings

Recent major analysts updates

Feb 14, 25 Maxim Group
Buy
Nov 25, 24 HC Wainwright & Co.
Neutral
Apr 12, 24 Cantor Fitzgerald
Neutral
Mar 6, 24 HC Wainwright & Co.
Buy
Nov 21, 23 Cantor Fitzgerald
Neutral
Nov 20, 23 HC Wainwright & Co.
Buy
Sep 26, 23 Cantor Fitzgerald
Overweight
Sep 22, 23 HC Wainwright & Co.
Buy
Sep 14, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Mainz Biomed BV?
  • Does Mainz Biomed BV pay dividends?
  • What sector is Mainz Biomed BV in?
  • What industry is Mainz Biomed BV in?
  • What country is Mainz Biomed BV based in?
  • When did Mainz Biomed BV go public?
  • Is Mainz Biomed BV in the S&P 500?
  • Is Mainz Biomed BV in the NASDAQ 100?
  • Is Mainz Biomed BV in the Dow Jones?
  • When was Mainz Biomed BV's last earnings report?
  • When does Mainz Biomed BV report earnings?
  • Should I buy Mainz Biomed BV stock now?

What is the ticker symbol for Mainz Biomed BV?

The ticker symbol for Mainz Biomed BV is NASDAQ:MYNZ

Does Mainz Biomed BV pay dividends?

No, Mainz Biomed BV does not pay dividends

What sector is Mainz Biomed BV in?

Mainz Biomed BV is in the Healthcare sector

What industry is Mainz Biomed BV in?

Mainz Biomed BV is in the Diagnostics & Research industry

What country is Mainz Biomed BV based in?

Mainz Biomed BV is headquartered in Germany

When did Mainz Biomed BV go public?

Mainz Biomed BV's initial public offering (IPO) was on November 5, 2021

Is Mainz Biomed BV in the S&P 500?

No, Mainz Biomed BV is not included in the S&P 500 index

Is Mainz Biomed BV in the NASDAQ 100?

No, Mainz Biomed BV is not included in the NASDAQ 100 index

Is Mainz Biomed BV in the Dow Jones?

No, Mainz Biomed BV is not included in the Dow Jones index

When was Mainz Biomed BV's last earnings report?

Mainz Biomed BV's most recent earnings report was on Oct 21, 2024

When does Mainz Biomed BV report earnings?

The next expected earnings date for Mainz Biomed BV is Feb 25, 2025

Should I buy Mainz Biomed BV stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions